Shares of Torrent Pharmaceuticals witnessed an uptick on the BSE, trading at Rs. 3481.55, reflecting a rise of 46.85 points or 1.36% compared to its previous close of Rs. 3434.70.

The stock opened at Rs. 3445.05 and reached a peak of Rs. 3574.00, with a low of Rs. 3445.05 during the day. A total of 11,472 shares exchanged hands in today's session.

This BSE 'A' group stock, with a face value of Rs. 5, hit its 52-week high of Rs. 3574.00 on August 30, 2024, while its 52-week low was Rs. 1771.35 on September 1, 2023.

Over the past week, the scrip fluctuated between Rs. 3574.00 and Rs. 3269.65. The company's market capitalization currently stands at Rs. 1,18,146.23 crore.

The promoter shareholding is at 71.25%, while institutional and non-institutional investors hold 21.49% and 7.26% respectively.

Torrent Pharmaceuticals also announced that it has received an Establishment Inspection Report (EIR) from the USFDA for its Indrad, Gujarat facility, with a Voluntary Action Indicated (VAI) classification. The inspection, which took place between June 3 and June 12, 2024, has now been successfully closed.

Torrent Pharmaceuticals is the leading entity of the Torrent group and specializes in cardiovascular and central nervous system drugs. It also has a significant presence in gastro-intestinal, diabetology, anti-infective, and pain management areas.